Connect with us

Cannabis News

Brix celebrates first anniversary with planned expansion

Published

on

The CANNECTICT’s CANNEBIS market will be marked by 23.8 million in BRIX, with the marketing of American retail Americans, the marketing of award-winning products and Connecticut consolidates the company that Connecticut produces Connecticut’s CANNABIS brand.

From a 10,000-square-micro-cultivation facility of Britain, Brix was launched with a mission to democratize cannabis access to Connecticut. Twelve months later, the company managed to distribute a state-of-the-art center of Xpocanna’s 2025 x cup competition and secured the exclusive Connecticut collaboration with the legendary Chemdog genetics.

“This first year show our commitment to Connecticut’s cannabis industry, quality and community commitment,” Cory McCain said, Brix CANNABIS General Manager. “We have built a torque if we are linked to our local market while constantly delivering products that exceed expectations.”

Strategic product expansion
Brix ‘Summer Brix’ campaign spread the market accessibility through strategic prices by introducing two product lines. Brix Remix Series has pre-rolls premiums, experts with cultivated voltage combinations, bad (crostata x kim d) and fresh shots (Mac Stomper Xoboia). Lil ‘Budz Collection offers a small 7-gram-formed flower, which allows you to place a higher power limit for adults in Connecticut.

© Brix Cannabis

From Premium Flower Specialist, Brix has spread across multiple categories: pre-artisanal rolls, to throw 0.5g, and 510 cartridges.

Industry Declaration and collaborations
Brix’s purple milk tension 2025 Xpocanna X was captured in the first place of the best Indica Flower. Company Connecticut has exclusive collaboration with Cannabis Legend to Greg Krzanowski involves Precious Chemdog voltages, marketing through the Chem 91 Brix platform.

State availability and community impact
BRIX products are available in the main sellers of Connecticut, including the 420 British storage, is located in the Croppage of Crop – and has high-collective locations in Hamden, Bridgeport, New London and Torrington.

Beyond product innovation, it protects fine and well-being workshops for young people in Britain for young people in Britain. He collaborates with the Police League culture and supports cultural events in the RidgeField Playhouse.

For more information:
Brix Cannabis
(Protected by email)
brixofficial.com

Cannabis News

Critical updates for cannabis taxpayers as the 2025 filing deadline approaches

Published

on

By











With the April 2025 tax return filing deadline fast approaching, cannabis companies must once again face the burden of Section 280E of the Internal Revenue Code (“Section 280E”). Despite significant developments over the past year — including a major executive order from President Trump and the IRS, for the first time, disclosing legal reasoning funds to keep state cannabis “within the meaning” of Section 280E — taxpayer scrutiny remains the same.

However, whether substantively or psychologically, these recent developments weigh on how taxpayers should deal with Section 280E. Below, we summarize the key developments that cannabis taxpayers should be aware of as they prepare their 2025 returns.

As discussed in previous publications, Section 280E provides: “(e) no deduction or credit shall be allowed for any amount paid or incurred in the course of any trade or business during the taxable year, if such trade or business (or the activities constituting such trade or business) is trafficking in controlled substances (controlled substance classes I and II prohibited by State or Federal law).

Because cannabis is now listed as a Schedule I controlled substance under the Controlled Substances Act (CSA), the IRS has consistently maintained that Section 280E applies to state-licensed cannabis businesses, significantly increasing their effective tax rates.

Read more at JD above










Continue Reading

Cannabis News

Louisiana Senators Approve Bill To Allow Medical Marijuana Use In Hospitals For Terminally Ill Patients

Published

on

By

A Louisiana Senate panel has advanced a bill to allow patients with terminal and irreversible conditions to use medical marijuana in hospitals.

The Senate Health and Welfare Committee approved the legislation, SB 270 (D) by Sen. Katrina Jackson-Andrews, with amendments, on a voice vote Wednesday.

“This bill was introduced at the request of voters who believe that therapeutic medical marijuana, which is already legal in this state, should be offered in hospitals when the terminally ill or otherwise need the comfort of this medicine,” Jackson-Andrews said before the vote.

Under the proposal, hospitals would have to create written policies to allow covered patients to consume medical cannabis in forms other than smoking or vaporizing it.

Under an amendment approved by the panel, emergency or outpatient departments would be exempt from the policy. The revised legislation also clarifies that patients and primary caregivers are responsible for obtaining and administering medical marijuana, which “must be securely stored at all times in a sealed container provided by the patient.”

Health care professionals and staff would be prohibited from “administering, storing, retrieving, or assisting a patient with medical marijuana.” the text he says

The amendment, which the proponent worked out with the help of the Louisiana Hospital Association, also allows hospitals to opt out of the policy if federal officials take action against any health care facility in the state regarding the use of medical cannabis, instead of allowing those specifically targeted to stop serving.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Meanwhile, in Louisiana, the Senate Health and Welfare Committee passed a bill last week create a pilot psychedelic-assisted therapy program using opioid settlement dollars to fund clinical trials to develop alternative treatments such as psilocybin and ibogaine.

Lawmakers are also considering a bill creating a pilot program to legalize marijuana for adults in the state, in the end, to determine whether the reform should be expanded and permanently codified.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Cresco Labs gets Texas license

Published

on

By











Cresco Labs has obtained a Texas Compassionate Use Program License. It is a vertically integrated license that allows Cresco Labs to cultivate, process and distribute medical cannabis.

“Texas patients deserve access to consistent, quality medicine, and we’re excited. Our track record in medical markets reflects our ability to build strong programs that put patients and communities first,” said Charlie Bachtell, CEO of Cresco Labs. “Winning a license in Texas through a merit-based application demonstrates Cresco Labs’ deep regulatory expertise and thoughtful approach to meaningful local engagement. Organic licenses enable capital-efficient market entry, and our cash flow and balance sheet give us the financial flexibility to invest in and grow our scaled platform for the long term.”

This license advances Cresco Labs’ state-by-state growth strategy and ensures access to one of the largest patient populations in the United States. Texas is the nation’s second most populous state, approaching 30 million people, and continues to see ongoing legislative efforts to improve patient access and expand eligibility.










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media